We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$112B
AUM Growth
-$23.9B
Cap. Flow
-$21.6B
Cap. Flow %
-19.26%
Top 10 Hldgs %
10.96%
Holding
4,902
New
569
Increased
1,472
Reduced
1,734
Closed
704

Sector Composition

Rank Sector Weight
1 Technology 15.18%
2 Healthcare 9.91%
3 Consumer Discretionary 9.25%
4 Financials 6.45%
5 Industrials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WW
3951
PUT
DELISTED
WW International
WW
$36.6K ﹤0.01%
70,000
-200
-0.3% -$174
MGNX icon
3952
MacroGenics
MGNX
$235M
$36.4K ﹤0.01%
+28,700
New +$75K
IROHR
3953
DELISTED
Iron Horse Acquisitions Corp Right
IROHR
$35.7K ﹤0.01%
119,035
NOEMW
3954
CO2 Energy Transition Corp Warrant
NOEMW
$35K ﹤0.01%
+280,000
New +$24.3K
PL.WS
3955
DELISTED
Planet Labs PBC Warrants
PL.WS
$34.3K ﹤0.01%
52,798
BRLSW icon
3956
Borealis Foods Inc Warrant
BRLSW
$33.3K ﹤0.01%
300,000
SBCWW
3957
SBC Medical Group Warrants
SBCWW
$2.99M
$32.1K ﹤0.01%
172,500
GSRTR
3958
DELISTED
GSR III Acquisition Corp Right
GSRTR
$31.5K ﹤0.01%
21,428
NMRA icon
3959
Neumora Therapeutics
NMRA
$276M
$30.7K ﹤0.01%
+30,748
New +$52.6K
ANSCW
3960
Agriculture & Natural Solutions Acquisition Corp Warrant
ANSCW
$30K ﹤0.01%
100,000
TAVIR
3961
Tavia Acquisition Corp Right
TAVIR
$30K ﹤0.01%
200,000
AAM.WS
3962
DELISTED
AA Mission Acquisition Corp Warrants
AAM.WS
$29.9K ﹤0.01%
450,000
ANVS icon
3963
Annovis Bio
ANVS
$70.6M
$28.2K ﹤0.01%
+18,789
New +$57.5K
BDTX icon
3964
Black Diamond Therapeutics
BDTX
$101M
$27.7K ﹤0.01%
17,854
+537
+3% +$1.13K
CHARR
3965
Charlton Aria Acquisition Corp Rights
CHARR
$27K ﹤0.01%
150,000
LEGT.WS
3966
DELISTED
Legato Merger Corp III Warrants
LEGT.WS
$26.3K ﹤0.01%
136,100
BUJAR
3967
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Rights
BUJAR
$26K ﹤0.01%
100,000
RDACR
3968
Rising Dragon Acquisition Corp Rights
RDACR
$24.2K ﹤0.01%
150,000
EUDAW icon
3969
EUDA Health Holdings Warrant
EUDAW
$219K
$24K ﹤0.01%
200,000
DTSQR
3970
DT Cloud Star Acquisition Corp Right
DTSQR
$23.7K ﹤0.01%
150,000
AEVAW
3971
DELISTED
Aeva Technologies Warrants
AEVAW
$23.2K ﹤0.01%
294,000
BKHAR
3972
Black Hawk Acquisition Corp Rights
BKHAR
$22.5K ﹤0.01%
15,000
GLACR
3973
DELISTED
Global Lights Acquisition Corp Rights
GLACR
$22K ﹤0.01%
100,000
MACIW
3974
Melar Acquisition Corp I Warrant
MACIW
$21.9K ﹤0.01%
162,500
TLRY icon
3975
Tilray
TLRY
$479M
$21.6K ﹤0.01%
+3,289
New +$30.4K

Similar funds

D.E. Shaw & Co's Q1 2025 Portfolio in Review

As of Q1 2025, D.E. Shaw & Co held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

D.E. Shaw & Co withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, D.E. Shaw & Co opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.

  • D.E. Shaw & Co's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
  • D.E. Shaw & Co added most to GE Vernova in Q1 2025, an estimated $686M increase.
  • D.E. Shaw & Co's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
  • D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
  • D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
  • D.E. Shaw & Co opened 569 new positions and closed 704 in Q1 2025.
  • D.E. Shaw & Co's portfolio value fell 18% quarter-over-quarter to $112B.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.